Table 3.
Associations of 1 Standard Deviation Increment of Plasma Galectin-3 with Carotid Atherosclerosis Measures, Atherosclerosis Risk in Communities (ARIC) Study, 1996–1998.
Difference in Overall Mean IMT per 1 SD Galectin-3 Increment | ||||
Diff (mm) | SE | p | ||
Model 1 | 0.022 | 0.004 | <.0001 | |
Model 2 | 0.015 | 0.004 | <.0001 | |
Model 3 | 0.013 | 0.004 | 0.0005 | |
Odds Ratio for Mean Carotid IMT >75th Percentile per 1 SD Galectin-3 Increment | ||||
OR (95% CI) | p | |||
Model 1 | 1.15 (1.08–1.23) | <.0001 | ||
Model 2 | 1.09 (1.02–1.17) | 0.02 | ||
Model 3 | 1.08 (1.00–1.16) | 0.04 | ||
Odds Ratio for Carotid Plaque and/or Shadowing per 1 SD Galectin-3 Increment | ||||
OR (95% CI) | p | |||
Model 1 | 1.12 (1.05–1.19) | 0.0004 | ||
Model 2 | 1.09 (1.02 – 1.17) | 0.01 | ||
Model 3 | 1.08 (1.01 – 1.16) | 0.03 |
1 galectin-3 Standard Deviation = 4.5 ng/ml.
CI = confidence interval; IMT = Intima-media thickness; SD = Standard Deviation; SE = Standard Error.
Model 1: Adjusted for age, race-center, and gender.
Model 2: Additional adjustment for diabetes, systolic blood pressure, total cholesterol, High density lipoprotein cholesterol, triglycerides, body mass index, use of antihypertensive medication, use of anti-inflammatory medication, use of anti-ulcer medication, use of nutritional supplements, and estimated glomerular filtration rate.
Model 3: Additional adjustment for High-sensitivity C-reactive protein (log transformed).